• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by DuPont de Nemours Inc. (Amendment)

    2/13/24 4:55:53 PM ET
    $DD
    Major Chemicals
    Industrials
    Get the next $DD alert in real time by email
    SC 13G/A 1 tv0055-dupontdenemoursinc.htm SCHEDULE 13G/A dupontdenemoursinc

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G

    Under the Securities Exchange Act of 1934
    (Amendment No.: 7)*

    Name of issuer:  DuPont de Nemours Inc

    Title of Class of Securities:  Common Stock

    CUSIP Number:  26614N102

    Date of Event Which Requires Filing of this Statement: December 29, 2023

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on the following page(s))

     

     

    13G

    CUSIP No.:  26614N102

    1.  NAME OF REPORTING PERSON
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    The Vanguard Group - 23-1945930

    2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP

    A. 

    B.  X

    3.  SEC USE ONLY

    4.  CITIZENSHIP OF PLACE OF ORGANIZATION

    Pennsylvania

    (For questions 5-8, report the number of shares beneficially owned by each reporting person with:)

    5.  SOLE VOTING POWER

    0

    6.  SHARED VOTING POWER

    555,323

    7.  SOLE DISPOSITIVE POWER

    46,182,292

    8.  SHARED DISPOSITIVE POWER

    1,861,570

    9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    48,043,862

    10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    N/A

    11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    11.17%

    12.  TYPE OF REPORTING PERSON

    IA

     

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G
    Under the Securities Act of 1934

    Item 1(a) - Name of Issuer:

    DuPont de Nemours Inc

    Item 1(b) - Address of Issuer's Principal Executive Offices:

    974 Centre Road, Building 730
    Wilmington, DE 19805

    Item 2(a) - Name of Person Filing:

    The Vanguard Group - 23-1945930

    Item 2(b) – Address of Principal Business Office or, if none, residence:

    100 Vanguard Blvd.
    Malvern, PA 19355

    Item 2(c) – Citizenship:

    Pennsylvania

    Item 2(d) - Title of Class of Securities:

    Common Stock

    Item 2(e) - CUSIP Number

    26614N102

    Item 3 - Type of Filing:

    This statement is being filed pursuant to Rule 13d-1.  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

    Item 4 - Ownership:

      (a) Amount Beneficially Owned:

      (b) Percent of Class:

     

     

    (c)  Number of shares as to which such person has:

    (i)  sole power to vote or direct to vote:  

    (ii)  shared power to vote or direct to vote:  

    (iii)  sole power to dispose of or to direct the disposition of:  

    (iv)  shared power to dispose or to direct the disposition of:  

    Comments:

    The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.  

    Item 5 - Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐

    Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:

    The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.

    No one other person's interest in the securities reported herein is more than 5%.

    Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company:

    Not applicable

    Item 8 - Identification and Classification of Members of Group:

    Not applicable

    Item 9 - Notice of Dissolution of Group:

    Not applicable

    Item 10 - Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:  February 13, 2024

    By /s/ Ashley Grim
    Name: Ashley Grim
    Title:  Head of Global Fund Administration

    Get the next $DD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DD

    DatePrice TargetRatingAnalyst
    7/3/2025$75.00 → $85.00Buy
    Citigroup
    4/15/2025$75.00Underperform → Neutral
    BofA Securities
    4/14/2025$81.00Sector Weight → Overweight
    KeyBanc Capital Markets
    2/13/2025$85.00 → $89.00Underweight → Equal Weight
    Barclays
    1/17/2025$91.00Peer Perform → Outperform
    Wolfe Research
    10/7/2024$88.00 → $84.00Equal Weight → Underweight
    Barclays
    5/28/2024$85.00 → $95.00Neutral → Buy
    Citigroup
    5/24/2024$80.00 → $103.00Equal Weight → Overweight
    Wells Fargo
    More analyst ratings

    $DD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DuPont Launches Liveo™ C6-8XX Liquid Silicone Rubber Series for Healthcare Applications

    Improved-rheology medical-grade LSR offers process flexibility for fabricating medical devices, including devices intended for implantation in humans for less than 30 days, as well as for non-implant applications WILMINGTON, Del., Feb. 3, 2026 /PRNewswire/ -- DuPont (NYSE:DD) today announced the launch of Liveo™ C6-8XX Liquid Silicone Rubber (LSR), a new USP Class VI (C6) series of medical-grade, two-part silicone elastomers engineered to meet the stringent requirements of medical device applications. The Liveo™ C6-8XX LSR series delivers precision, reliability and processing

    2/3/26 9:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont Introduces DuPont™ AmberLite™ FPA57 Resin to Boost Efficiency in Organic Acid Purification

    Upgraded weak base anion resin delivers enhanced operating capacity, longer run lengths, and greater fouling resistance to support cost-efficient production of lactic and citric acids WILMINGTON, Del., Jan. 28, 2026 /PRNewswire/ -- DuPont (NYSE:DD) today announced the launch of DuPont™ AmberLite™ FPA57 resin, an innovative weak base anion resin designed to support the growing needs of organic acid manufacturers. Organic acids play a critical role across the food and beverage, personal care, biodegradable plastics, and pharmaceutical industries. They are essential in processes

    1/28/26 9:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont Announces 3rd Annual Tyvek® Sustainable Healthcare Packaging Awards Program

    Applications now being accepted for this awards program recognizing excellence in healthcare packaging initiatives that utilize Tyvek® to help drive and promote continued innovation in sustainability WILMINGTON, Del., Jan. 26, 2026 /PRNewswire/ -- DuPont (NYSE:DD) today announced that it is accepting applications for the 3rd annual global Tyvek® Sustainable Healthcare Packaging Awards program. The awards program is designed to recognize companies and organizations across the healthcare industry who are embracing and driving sustainability throughout the packaging lifecycle. T

    1/26/26 9:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    SEC Filings

    View All

    DuPont de Nemours Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - DuPont de Nemours, Inc. (0001666700) (Filer)

    1/20/26 5:00:08 PM ET
    $DD
    Major Chemicals
    Industrials

    DuPont de Nemours Inc. filed SEC Form 8-K: Other Events

    8-K - DuPont de Nemours, Inc. (0001666700) (Filer)

    12/4/25 4:42:35 PM ET
    $DD
    Major Chemicals
    Industrials

    DuPont de Nemours Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

    8-K - DuPont de Nemours, Inc. (0001666700) (Filer)

    11/19/25 4:21:47 PM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Macpherson Donald G claimed no ownership of stock in the company (SEC Form 3)

    3 - DuPont de Nemours, Inc. (0001666700) (Issuer)

    1/28/26 4:38:13 PM ET
    $DD
    Major Chemicals
    Industrials

    Director Breen Edward D covered exercise/tax liability with 24,574 shares, decreasing direct ownership by 8% to 301,048 units (SEC Form 4)

    4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

    1/5/26 5:00:20 PM ET
    $DD
    Major Chemicals
    Industrials

    Senior Vice President & CHRO Raia Christopher covered exercise/tax liability with 2,793 shares, decreasing direct ownership by 3% to 80,255 units (SEC Form 4)

    4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

    1/5/26 4:59:10 PM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup reiterated coverage on DuPont with a new price target

    Citigroup reiterated coverage of DuPont with a rating of Buy and set a new price target of $85.00 from $75.00 previously

    7/3/25 9:18:04 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont upgraded by BofA Securities with a new price target

    BofA Securities upgraded DuPont from Underperform to Neutral and set a new price target of $75.00

    4/15/25 8:43:17 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont upgraded by KeyBanc Capital Markets with a new price target

    KeyBanc Capital Markets upgraded DuPont from Sector Weight to Overweight and set a new price target of $81.00

    4/14/25 8:04:47 AM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Leadership Updates

    Live Leadership Updates

    View All

    DuPont Announces Appointment of D.G. Macpherson to Board of Directors

    WILMINGTON, Del., Jan. 20, 2026 /PRNewswire/ -- DuPont (NYSE:DD) today announced the appointment of D.G. Macpherson to its Board of Directors, effective immediately. "We are very pleased to welcome D.G. to the DuPont board," said Lori Koch, DuPont Chief Executive Officer. "D.G. brings deep expertise in operational excellence, supply chain optimization, and business transformation, which will be invaluable as we execute our growth strategy and deliver long-term value to shareholders, customers, and employees. His passion for innovation and commitment to continuous improvement m

    1/20/26 4:15:00 PM ET
    $DD
    Major Chemicals
    Industrials

    Solstice Advance Materials and Qnity Electronics Set to Join S&P 500; Others to Join S&P SmallCap 600

    NEW YORK, Oct. 27, 2025 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P SmallCap 600: Solstice Advance Materials Inc. (NASD: SOLS) will replace CarMax Inc. (NYSE:KMX) in the S&P 500, and CarMax will replace USANA Health Sciences Inc. (NYSE:USNA) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, October 31. S&P 500 and 100 constituent Honeywell International Inc. (NASD: HON) is spinning off Solstice Advance Materials in a transaction expected to be completed on October 30. Post spin-off, Honeywell International will remain in the S&P 500 and 100. CarMax and USANA Health Sciences no longer represent the large cap and small c

    10/27/25 6:10:00 PM ET
    $CAL
    $DD
    $EMN
    Shoe Manufacturing
    Consumer Discretionary
    Major Chemicals
    Industrials

    DuPont Announces Appointment of Kurt McMaken to Board of Directors

    WILMINGTON, Del., Feb. 21, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced the appointment of Kurt McMaken to its Board of Directors, effective immediately. Mr. McMaken will serve on the Audit committee and Nomination and Governance committee. "We are pleased to welcome Kurt to DuPont's Board of Directors," said DuPont Executive Chairman Ed Breen. "Kurt's global business expertise in the manufacturing sector and extensive background in finance and strategic planning make him well suited to help guide DuPont's growth and value creation strategies. We look forward to his c

    2/21/25 4:15:00 PM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Financials

    Live finance-specific insights

    View All

    DuPont Schedules Fourth Quarter 2025 Earnings Conference Call

    WILMINGTON, Del., Jan. 21, 2026 /PRNewswire/ -- DuPont (NYSE:DD) will release its fourth quarter and full year 2025 financial results at 6:00 a.m. ET on Tuesday, February 10, 2026. In addition, the company will host a conference call at 8:00 a.m. ET that day. The event will be webcast live and can be accessed on DuPont's Investors Relations webpage. A replay, along with the earnings release and supporting materials, will also be posted to the website. The dial-in number for the conference call is 888-440-4172 toll-free within the U.S. or +1-646-960-0673. The conference ID is 5

    1/21/26 8:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont Reports Third Quarter 2025 Results; Announces Plans to Return Cash to Shareholders

    Exceeds 3Q 2025 Guidance for Total DuPont Raises FY 2025 Earnings Guidance for New DuPont Announces $2 Billion Share Repurchase Authorization, $500 Million Accelerated Share Repurchase and New DuPont Quarterly Dividend Third Quarter 2025 Highlights Net Sales of $3.1 billion increased 7%; organic sales increased 6% versus year-ago periodGAAP Income from continuing operations of $308 million; operating EBITDA of $840 millionGAAP EPS from continuing operations of $0.70; adjusted EPS of $1.09Cash provided by operating activities from continuing operations of $591 million; transaction-adjusted free cash flow of $576 millionRaises FY 2025 operating EBITDA guidance for new DuPont to $1.6 billionCap

    11/6/25 6:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont Schedules Third Quarter 2025 Earnings Conference Call

    WILMINGTON, Del., Oct. 20, 2025 /PRNewswire/ -- DuPont (NYSE:DD) will release its third quarter financial results at 6:00 a.m. ET on Thursday, November 6, 2025. In addition, the company will host a conference call at 8:00 a.m. ET that day. The event will be webcast live and can be accessed on DuPont's Investors Relations webpage. A replay, along with the earnings release and supporting materials, will also be posted to the website. The dial-in number for the conference call is 888-440-4172 toll-free within the U.S. or +1-646-960-0673. The conference ID is 5994046. DuPont will

    10/20/25 4:05:00 PM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by DuPont de Nemours Inc.

    SC 13G/A - DuPont de Nemours, Inc. (0001666700) (Subject)

    11/12/24 11:54:03 AM ET
    $DD
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by DuPont de Nemours Inc. (Amendment)

    SC 13G/A - DuPont de Nemours, Inc. (0001666700) (Subject)

    2/13/24 4:55:53 PM ET
    $DD
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by DuPont de Nemours Inc.

    SC 13G - DuPont de Nemours, Inc. (0001666700) (Subject)

    2/9/24 11:49:03 AM ET
    $DD
    Major Chemicals
    Industrials